Bicycle raises £40 million for peptide therapies

Bicycle Therapeutics Ltd has raised £40 million in a Series B financing round to bring its first peptide-based therapeutic into the clinic. The financing was led by Vertex Ventures, along with Cambridge Innovation Capital and the Longwood Fund.